Furthermore, ERβ positive immunoreactivity in tumour cells increased with dedifferentiation and increasing tumour stage in both types of oesophageal cancer and has prompted suggestions that ERβ status is a potentially useful marker of worsening disease progression [39]. Here, ESR2 is linked to carcinoma of esophagus.